CMO revenue could double in Europe, says Frost & Sullivan. New analysis from Frost & Sullivan, "European Pharmaceutical and Biotech Contract Manufacturing Markets," finds that the European pharmaceutical contract manufacturing market earned revenues of $10.02 billion in 2011 and estimates this to reach $20.75 billion in 2018. Over the same period, the European biotech contract manufacturing market is set to expand from $1.21 billion to an estimated $2.67 billion.
Burrill & Co to raise $200m Israel life sciences fund. Sources inform ''Globes'' that Burrill & Company, one of the world's leading life sciences investment company is establishing a fund to invest in Israeli companies. The fund's special advisor Jeff Miller said, "We met with the Chief Scientist and we will see what collaboration is possible."